ALBANY, NY – MARCH 27, 2024 – Earlier today, elected officials stood alongside cancer survivors, patient advocates and public health leaders to highlight opportunities in the 2024-25 FY budget aimed at helping more New Yorkers prevent cancer, detect it early and alleviate its bur
American Cancer Society Cancer Action Network (ACS CAN) volunteers from across Hawaii met with their legislators at the Hawaii State Capitol Thursday to urge them to support HB1301. If enacted, the policy would enable funding for a multiethnic cohort study by the University of Hawaii Cancer Center, the only National Cancer Institute-designated cancer center in the Hawaii Pacific region.
Statement from American Cancer Society Cancer Action Network (ACS CAN) Nebraska Government Relations Director Megan Word
In a major victory for public health, a three-judge panel of the U.S. Court of Appeals for the Fifth Circuit has unanimously upheld graphic health warnings on cigarette packs and advertising required under a 2020 FDA rule.
ATLANTA, Georgia – March 21, 2024 – The Georgia Senate’s regulated industries committee failed to pass HB 1077 today in a tied vote. The bill would have cleared the way for a customized solution to closing the coverage gap in Georgia.
The following was originally published in the Albany Times Union on March 21, 2024.
Nation’s Leading Cancer Advocacy Organization Urges Support of LD2028 Minority Report to Protect Public Health
A series of TV advertisements paid for by the American Cancer Society Cancer Action Network (ACS CAN) launched today. The latest ad calls attention to the diverse range of people caught in the Medicaid coverage gap, including military veterans, their families, and cancer patients. The ad is hitting the airwaves as the Senate continues its work toward its plan to provide more hard-working Mississippians access to health care through Medicaid.
WASHINGTON, DC— 21 de marzo de 2024 — Hoy, el Congreso publicó una serie de proyectos de ley de asignaciones presupuestarias destinadas a finalizar el financiamiento del año fiscal 2024 que incluye un aumento de $300 millones en el financiamiento para el presupuesto base del Instituto Nacional de Salud (NIH, siglas en inglés), incluido un aumento de $120 millones en fondos discrecionales para el Instituto Nacional del Cáncer (NCI), un modesto aumento de $500,000 para los programas de detección y prevención del cáncer de los Centros para el Control y la Prevención de Enfermedades (CDC, siglas en inglés) y mantiene el nivel de financiamiento actual para la Agencia de Proyectos de Investigación Avanzada para la Salud (ARPA-H, siglas en inglés) en $1.5 mil millones.
Today, the American Cancer Society Cancer Action Network submitted a statement for the record to the House Energy & Commerce Committee Health Subcommittee in regards to their hearing on Evaluating Approaches to Diagnostic Test Regulation and the impact of the FDA’s proposed rule.